Updated European Recommendations on Cervical Screening at EUROGIN 2026
New European Screening Recommendations Reflect the Impact of HPV Vaccination on Population Risk
EUROGIN 2026
IARC announces updated European recommendations on cervical cancer screening at EUROGIN 2026. The recommendations introduce tailored strategies for vaccinated populations.
Vaccination
For cohorts with high vaccination coverage, screening intervals can be extended to ten years after a negative HPV test. For populations with lower coverage, standard approaches remain in place. The guidance is informed by modelling of multiple screening strategies. These updates represent a shift toward risk-based screening approaches.
#EUCanScreen #HPV #HPVVaccination #CervicalCancer #CancerScreening
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
This website is managed by 6th DYPEDE, Greece.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959